Paradigm Neuroscience

Paradigm Neuroscience is the trade name used by Paradigm Consulting LLC, a U.S.-based neuroscience drug development consulting firm. The company provides consulting services for therapeutics development in neurology and psychiatry, spanning early-phase clinical development through post-marketing studies. Its work appears to center on clinical development strategy, regulatory planning, protocol development, advisory boards, publication support, and broader medical affairs support. The business is led by neurologist Joe Hulihan, who founded the practice in 2015 after senior roles in pharmaceutical neuroscience development and academia. Paradigm Neuroscience does not appear to be a drug developer with an internal therapeutic pipeline; rather, it operates as a specialized neurotherapeutics consultancy serving biopharma clients.